Skip to main content

uniQure N.V.

QURE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001590560

In the last 90 days, uniQure N.V. insiders filed 0 open-market purchases and 3 sales; 254 institutions reported holding it in 13F filings for Q2 2026, worth $3.02B in total; Maverick Capital is the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by uniQure N.V. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
3 filings
3 insiders, $3.33M in total
Insiders trading
3
Net value
−$3.33M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for uniQure N.V., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for uniQure N.V.
NameTitleLast reported holdingLast filingFilings, past year
Kapusta Matthew CCEO, Managing Director519,227Jul 7, 20266
Abi-Saab WalidChief Medical Officer148,235Jul 2, 20265
Kaye JackDirector25,996Jul 2, 20266
Balachandran MadhavanDirector43,254Jun 22, 20263
Potts JeannetteChief Legal Officer133,246Jun 17, 20263
Post Leonard EDirector35,494Jun 12, 20261
Meek David D.Director39,747Jun 12, 20261
Gut RobertDirector32,259Jun 12, 20263
Springhorn Jeremy P.Director43,251Jun 12, 20261
Jacques Rachelle SuzanneDirector33,903Jun 12, 20261
O'Keefe KylieChief Customer & Strat Officer108,864Jun 12, 20262
Klemt ChristianChief Financial Officer226,581Mar 6, 20263
Caloz PierreChief Operating Officer115,707Jun 20, 20240
Soteropoulos PaulaDirector20,203Jun 17, 20240
Dolmetsch RicardoPresident, R&D163,404Sep 20, 20230
Kuta Alexander Edward IIIExecutive VP, Operations90,381Mar 9, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 24, 2025 (view filing)Jun 204 daysPost Leonard EDirectorSSale−2.11K$14.45−$30.5K−6.6%29.9K after
Jun 24, 2025 (view filing)Jun 204 daysSpringhorn Jeremy P.DirectorSSale−2.11K$14.45−$30.5K−5.3%37.7K after
Jul 1, 2025 (view filing)Jun 274 daysAbi-Saab WalidChief Medical OfficerSSale−1.47K$13.92−$20.4K−1.0%150.4K after
Sep 26, 2025 (view filing)Sep 24-262 daysKlemt ChristianChief Financial OfficerSSale−18.0K$52.51−$945.1K−7.6%217.7K after2 lots10b5-1
Sep 26, 2025 (view filing)Sep 242 daysKapusta Matthew CCEO, Managing DirectorSSale−226.3K$41.46−$9.38M−25.8%651.5K after5 lots10b5-1
Nov 6, 2025 (view filing)Nov 42 daysKaye JackDirectorSSale−38.8K$30.34−$1.18M−65.5%20.4K after3 lots10b5-1
Nov 10, 2025 (view filing)Nov 64 daysGut RobertDirectorSSale−31.4K$27.26−$856.9K−43.9%40.1K after2 lots10b5-1
Jan 12, 2026 (view filing)Jan 93 daysKaye JackDirectorSSale−6.39K$27.28−$174.3K−23.8%20.4K after10b5-1
Jan 14, 2026 (view filing)Jan 122 daysGut RobertDirectorSSale−25.6K$24.62−$630.5K−44.2%32.3K after3 lots10b5-1
Feb 27, 2026 (view filing)Feb 252 daysKlemt ChristianChief Financial OfficerSSale−6.22K$23.86−$148.3K−2.9%211.5K after
Feb 27, 2026 (view filing)Feb 252 daysKapusta Matthew CCEO, Managing DirectorSSale−12.4K$23.86−$295.3K−1.9%639.1K after
Mar 4, 2026 (view filing)Mar 22 daysAbi-Saab WalidChief Medical OfficerSSale−1.66K$9.95−$16.5K−1.1%148.8K after
Mar 4, 2026 (view filing)Mar 22 daysPotts JeannetteChief Legal OfficerSSale−8.58K$9.95−$85.4K−7.5%106.5K after
Mar 4, 2026 (view filing)Mar 22 daysKlemt ChristianChief Financial OfficerSSale−12.5K$9.95−$124.7K−5.9%199.0K after
Mar 4, 2026 (view filing)Mar 22 daysKapusta Matthew CCEO, Managing DirectorSSale−34.4K$9.95−$342.6K−5.4%604.6K after
Mar 6, 2026 (view filing)Mar 42 daysKlemt ChristianChief Financial OfficerSSale−12.0K$9.06−$108.7K−5.0%226.6K after
Mar 6, 2026 (view filing)Mar 42 daysPotts JeannetteChief Legal OfficerSSale−3.41K$9.06−$30.9K−2.4%138.5K after
Mar 6, 2026 (view filing)Mar 42 daysAbi-Saab WalidChief Medical OfficerSSale−808$9.06−$7.32K−0.4%189.7K after
Mar 6, 2026 (view filing)Mar 42 daysKapusta Matthew CCEO, Managing DirectorSSale−14.6K$9.06−$132.1K−2.2%660.7K after
May 12, 2026 (view filing)May 84 daysAbi-Saab WalidChief Medical OfficerSSale−45.0K$25.06−$1.13M−21.0%169.7K after2 lots10b5-1
Jun 5, 2026 (view filing)Jun 32 daysKaye JackDirectorSSale−2.65K$30.01−$79.4K−11.5%20.4K after10b5-1
Jun 12, 2026 (view filing)Jun 111 dayBalachandran MadhavanDirectorSSale−1.99K$27.06−$53.9K−4.4%43.3K after
Jun 12, 2026 (view filing)Jun 111 dayJacques Rachelle SuzanneDirectorSSale−1.99K$27.06−$53.9K−5.6%33.9K after
Jun 12, 2026 (view filing)Jun 111 dayKaye JackDirectorSSale−1.99K$27.06−$53.9K−7.1%26.0K after
Jun 12, 2026 (view filing)Jun 111 dayPost Leonard EDirectorSSale−1.99K$27.06−$53.9K−5.3%35.5K after
Jun 12, 2026 (view filing)Jun 111 daySpringhorn Jeremy P.DirectorSSale−1.99K$27.06−$53.9K−4.4%43.3K after
Jun 12, 2026 (view filing)Jun 111 dayO'Keefe KylieChief Customer & Strat OfficerSSale−15.9K$27.06−$431.2K−12.8%108.9K after
Jun 12, 2026 (view filing)Jun 10-112 daysGut RobertDirectorSSale−10.3K$26.32−$270.5K−24.2%32.3K after4 lots10b5-1
Jun 12, 2026 (view filing)Jun 111 dayMeek David D.DirectorSSale−1.99K$27.06−$53.9K−4.8%39.7K after
Jun 17, 2026 (view filing)Jun 152 daysPotts JeannetteChief Legal OfficerSSale−5.24K$27.67−$144.9K−3.8%133.2K after
Jun 17, 2026 (view filing)Jun 152 daysBalachandran MadhavanDirectorSSale−10.0K$27.85−$278.5K−18.8%43.3K after10b5-1
Jun 22, 2026 (view filing)Jun 175 daysKaye JackDirectorSSale−5.29K$42.57−$225.4K−16.9%26.0K after10b5-1
Jun 22, 2026 (view filing)Jun 175 daysBalachandran MadhavanDirectorSSale−11.7K$45.06−$526.5K−21.3%43.3K after3 lots10b5-1
Jun 22, 2026 (view filing)Jun 17-185 daysKapusta Matthew CCEO, Managing DirectorSSale−206.1K$45.47−$9.37M−28.3%521.8K after8 lots10b5-1
Jun 26, 2026 (view filing)Jun 24-252 daysKapusta Matthew CCEO, Managing DirectorSSale−35.4K$50.02−$1.77M−6.4%519.2K after2 lots10b5-1
Jun 30, 2026 (view filing)Jun 264 daysAbi-Saab WalidChief Medical OfficerSSale−1.43K$46.86−$67.2K−0.8%168.2K after
Jul 2, 2026 (view filing)4:54 PM ETJun 302 daysKaye JackDirectorSSale−21.2K$46.44−$983.0K−44.9%26.0K after2 lots10b5-1
Jul 2, 2026 (view filing)4:59 PM ETJun 302 daysAbi-Saab WalidChief Medical OfficerSSale−30.0K$46.42−$1.39M−16.8%148.2K after2 lots10b5-1
Jul 7, 2026 (view filing)4:47 PM ETJul 25 daysKapusta Matthew CCEO, Managing DirectorSSale−21.1K$45.16−$952.1K−3.9%519.2K after3 lots10b5-1